ANTI-TIF1-G POSITIVE DERMATOMYOSITIS WITH SEVERE OROPHARYNGEAL INVOLVEMENT AFTER IMMUNE CHECKPOINT INHIBITORS

被引：0

作者：

Tonutti, A. ^{[1
,2
]}

Luciano, N. ^{[3
]}

Ceribelli, A. ^{[1
,2
]}

Sonaglia, A. ^{[3
]}

Renna, D. ^{[3
]}

Repici, A. ^{[1
,4
]}

Lania, A. ^{[1
]}

Lleo, A. ^{[5
]}

De Nicola, S. ^{[6
]}

Bussini, L. ^{[7
]}

Morelli, P. ^{[7
]}

Pagani, M. ^{[8
]}

Selmi, C. ^{[1
,2
]}

De Santis, M. ^{[1
,2
]}

机构：

[1] IRCCS Humanitas Res Hosp, Milan, Italy

[2] Humanitas Univ, Rheumatol & Clin Immunol, Milan, Rozzano, Italy

[3] IRCCS Humanitas Res Hosp, Rheumatol & Clin Immunol, Milan, Rozzano, Italy

[4] Humanitas Univ, Gastroenterol & Digest Endoscopy, Milan, Rozzano, Italy

[5] Humanitas Univ, Liver Unit, Milan, Rozzano, Italy

[6] IRCCS Humanitas Res Hosp, Liver Unit, Milan, Rozzano, Italy

[7] IRCCS Humanitas Res Hosp, Infect Dis, Milan, Rozzano, Italy

[8] IRCCS Humanitas Res Hosp, Neuroctr, Neurorehabil Unit, Milan, Rozzano, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Myositis; Malignancy; Autoantibodies;

D O I：

10.1136/annrheumdis-2023-eular.3685

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0576

引用

页码：558 / 558

页数：1

共 50 条

[1] Anti-TIF1-γ antibody-positive dermatomyositis
Li, Chia-Lun
Ma, Sheng-Hsiang
Wu, Chen-Yi
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2583 - 2584
[2] NOVEL BIOMARKERS PREDICT WHETHER CANCER EMERGES IN ANTI-TIF1-G POSITIVE DM PATIENTS AT HIGH RISK FOR CANCER
Casciola-Rosen, Livia
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 408 - 408
[3] Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
Kotobuki, Yorihisa
Tonomura, Kyoko
Fujimoto, Manabu
IMMUNOLOGICAL MEDICINE, 2021, 44 (01) : 23 - 29
[4] CAN IMMUNE CHECKPOINT INHIBITORS BE SAFELY USED IN PATIENTS WITH MALIGNANCY AND SEVERE DERMATOMYOSITIS?
Pietsch, David
Bigby, Kieron
Hennessey, Ashleigh
INTERNAL MEDICINE JOURNAL, 2022, 52 : 34 - 34
[5] THE CLINICAL FEATURES OF ANTI-TIF1GAMMA ANTIBODY POSITIVE DERMATOMYOSITIS
Fujikawa, Yoshikazu
Akashi, Kengo
Katayama, Motoko
Yamashita, Mai
Nose, Yoko
Okano, Takaichi
Ueda, Yo
Sendo, Sho
Onishi, Akira
Saegusa, Jun
Morinobu, Akio
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1559 - 1559
[6] Anti-TIF-1γ Positive Juvenile Dermatomyositis Diagnosed with Atopic Dermatitis
Fujita, Yuji
Suzuki, Shotaro
Sato, Megumi
Matsushita, Takashi
Yoshihara, Shigemi
INDIAN JOURNAL OF PEDIATRICS, 2023, 91 (7): : 739 - 740
[7] Anti-TIF1-γ autoantibodies-positive dermatomyositis: where is the malignancy?
Zachou, Athena
Zouvelou, Vassiliki
Papadimas, George K.
Rentzos, Michael
Papadopoulos, Constantinos
RHEUMATOLOGY, 2018, 57 (04) : 756 - 756
[8] A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
Agrawal, Upasana
Sondhi, Manush
Smith, Alexandra Zamora
Nida, Syeda Sara
Umer, Sarwat
Hayat, Samina
Muzaffar, Kinza
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2024, 12
[9] Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 Antibody-Positive Dermatomyositis
Chen, Liang
Fallavollita, Sabrina
Sakr, Lama
Wang, Hangjun
Pusztaszeri, Marc
Esfahani, Khashayar
Pollak, Michael N.
Hudson, Marie
Leclair, Valerie
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (01)
[10] Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis
Motegi, Sei-ichiro
Sekiguchi, Akiko
Ikeuchi, Hidekazu
Sakairi, Toru
Ogawa, Hiroomi
Fujii, Takaaki
Sohda, Makoto
Yajima, Toshiki
Ida, Shota
Takayasu, Yukihiro
Shimoda, Yuki
Hiromura, Keiju
Saeki, Hiroshi
Shirabe, Ken
Chikamatsu, Kazuaki
Yokoo, Hideaki
Oyama, Tetsunari
Ishikawa, Osamu
JOURNAL OF DERMATOLOGY, 2020, 47 (12): : 1395 - 1402

← 1 2 3 4 5 →